{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T05:15:35Z","timestamp":1648617335231},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.eimc.2009.11.002","type":"journal-article","created":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T09:59:58Z","timestamp":1268128798000},"page":"199.e1-199.e33","source":"Crossref","is-referenced-by-count":1,"title":["Caracter\u00edsticas de los f\u00e1rmacos antiv\u00edricos frente a virus del grupo herpes actualizaci\u00f3n 2009"],"prefix":"10.1016","volume":"28","author":[{"given":"Montse","family":"Tuset","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"L\u00f3pez-Su\u00f1\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2009.11.002_bib1","series-title":"Cat\u00e1logo de Medicamentos. Colecci\u00f3n Consejo Plus","year":"2009"},{"key":"10.1016\/j.eimc.2009.11.002_bib2","series-title":"Drug Information Handbook 2009\u20132010","author":"Lacy","year":"2009"},{"key":"10.1016\/j.eimc.2009.11.002_bib3","unstructured":"Hopkins J. ABX Guide; 2009 [consultado 5\/7\/2009]. Disponible en: http:\/\/hopkins-abxguide.org\/."},{"key":"10.1016\/j.eimc.2009.11.002_bib4","unstructured":"Klasco RK. DRUGDEX\u00ae System. Colorado, USA: Thomson Micromedex, Greenwood Village; 2009 [consultado 5\/7\/2009]. Disponible en: http:\/\/www.thomsonhc.com."},{"key":"10.1016\/j.eimc.2009.11.002_bib5","series-title":"Gu\u00eda de Terap\u00e9utica Antimicrobiana 2009","year":"2009"},{"key":"10.1016\/j.eimc.2009.11.002_bib6","unstructured":"Product information. European Medicines Agency (EMEA); 2009 [consultado 5\/7\/2009]. Disponible en: http:\/\/www.emea.europa.eu\/htms\/human\/epar\/a.htm."},{"key":"10.1016\/j.eimc.2009.11.002_bib7","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1046\/j.1365-2036.2000.00857.x","article-title":"Unfavourable effects of colchicine in combination with interferon-alpha in the treatment of chronic hepatitis C","volume":"14","author":"Angelico","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.eimc.2009.11.002_bib8","first-page":"CD005582","article-title":"Corticosteroids for preventing postherpetic neuralgia","author":"He","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.eimc.2009.11.002_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1157\/13076175","article-title":"Documento de consenso GESIDA\/GESITRA-SEIMC, SPNS y ONT sobre trasplante de \u00f3rgano s\u00f3lido en pacientes infectados por el VIH en Espa\u00f1a (marzo 2005)","volume":"23","author":"Mir\u00f3","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1157\/13125642","article-title":"Prevenci\u00f3n de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el VIH en el a\u00f1o 2008. Recomendaciones del Grupo de Estudio del Sida (GESIDA)\/Plan Nacional sobre el Sida","volume":"26","year":"2008","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jinf.2008.03.004","article-title":"Chickenpox in adults-clinical management","volume":"57","author":"Tunbridge","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2009.11.002_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.11.002_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/bmj.39206.571042.AE","article-title":"Herpes zoster","volume":"334","author":"Wareham","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.eimc.2009.11.002_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/14787210.4.3.367","article-title":"Valacyclovir for the treatment of genital herpes","volume":"4","author":"Brantley","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.eimc.2009.11.002_bib15","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation\u2014a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.eimc.2009.11.002_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/589747","article-title":"The management of encephalitis: Clinical practice guidelines by the Infectious Diseases Society of America","volume":"47","author":"Tunkel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.11.002_bib17","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2165\/00003495-200666180-00016","article-title":"Famciclovir: A review of its use in herpes zoster and genital and orolabial herpes","volume":"66","author":"Simpson","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.eimc.2009.11.002_bib18","first-page":"401","article-title":"Infections in liver transplant recipients","volume":"25","author":"Aguado","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1157\/13109990","article-title":"Effects of viral infection on transplant recipients","volume":"25","author":"Caston","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib20","first-page":"639","article-title":"Infection in lung transplantation","volume":"25","author":"Gavalda","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib21","doi-asserted-by":"crossref","unstructured":"Glenny AM, Fernandez Mauleffinch LM, Pavitt S, Walsh T. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer. Cochrane Database Syst. Rev. 2009, Issue 1. Art. No.: CD006706. doi:10.1002\/14651858.CD006706.pub2.","DOI":"10.1002\/14651858.CD006706.pub2"},{"key":"10.1016\/j.eimc.2009.11.002_bib22","doi-asserted-by":"crossref","unstructured":"Wilhelmus KR. Therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst. Rev. 2008;23;(1)(1):CD002898. doi:10.1002\/14651858.CD002898.pub3.","DOI":"10.1002\/14651858.CD002898.pub3"},{"key":"10.1016\/j.eimc.2009.11.002_bib23","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/lt.21614","article-title":"Liver transplantation for hepatitis B: What is the best hepatitis B immune globulin\/antiviral regimen?","volume":"14","author":"Angus","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.eimc.2009.11.002_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1157\/13051908","article-title":"Caracter\u00edsticas de los f\u00e1rmacos antivirales","volume":"21","author":"Tuset","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib25","first-page":"1683","article-title":"Treatment and prevention of herpes labialis","volume":"54","author":"Opstelten","year":"2008","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.eimc.2009.11.002_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1468-3083.2008.02761.x","article-title":"Randomized clinical study comparing compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis","volume":"22","author":"Karlsmark","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.eimc.2009.11.002_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/09546630701593457","article-title":"Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: Results of a randomized, open-label trial","volume":"19","author":"Zschocke","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.eimc.2009.11.002_bib28","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/AAC.47.3.1072-1080.2003","article-title":"High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: Results of two randomized, placebo-controlled, multicenter studies","volume":"47","author":"Spruance","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.11.002_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaad.2006.02.031","article-title":"Single-dose, patient-initiated famciclovir: A randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis","volume":"55","author":"Spruance","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.eimc.2009.11.002_bib30","first-page":"77","article-title":"Famciclovir for cutaneous herpesvirus infections: An update and review of new single-day dosing indications","volume":"80","author":"Chacko","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.eimc.2009.11.002_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.eimc.2008.05.006","article-title":"Adult herpes simplex encephalitis: fifteen years\u2019 experience","volume":"27","author":"Riera-Mestre","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib32","unstructured":"Pahissa A, Lumbreras C, Gavald\u00e1 J, Cisneros JM, Mu\u00f1oz P. X-Infecciones en el paciente trasplantado. En: Aguado JM, Almirante B, Fort\u00fan J, editores. Protocolos cl\u00ednicos de la SEIMC. 2005. [consultado 27\/7\/2009]. Disponible en: http:\/\/www.seimc.org\/documentos\/protocolos\/clinicos\/"},{"key":"10.1016\/j.eimc.2009.11.002_bib33","unstructured":"Humar A, Chou S. CMV infection in solid organ transplantation: Clinical clues and prevention strategies. Robert Michael Educational Institute LLC; 2009 [consultado 27\/7\/2009]. Disponible en: http:\/\/www.rmei.com\/CMV555\/."},{"key":"10.1016\/j.eimc.2009.11.002_bib34","unstructured":"Gudiol F, Berenguer J, Lizasoa\u00edn M, Carratal\u00e1 J, Capdevila JA. XI-Infecciones en el paciente neutrop\u00e9nico. En: Aguado JM, Almirante B, Fort\u00fan J, editores. Protocolos cl\u00ednicos de la SEIMC. 2005. [consultado 27\/7\/2009]. Disponible en: http:\/\/www.seimc.org\/documentos\/protocolos\/clinicos\/"},{"key":"10.1016\/j.eimc.2009.11.002_bib35","unstructured":"Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases. Treatment Guidelines; 2006 [consultado 20\/8\/2009]. Disponible en: www.cdc.gov\/STD\/."},{"key":"10.1016\/j.eimc.2009.11.002_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1157\/13123842","volume":"26","year":"2008","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib37","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2165\/00003495-200060060-00007","article-title":"Current recommendations for the treatment of genital herpes","volume":"60","author":"Leung","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.eimc.2009.11.002_bib38","doi-asserted-by":"crossref","unstructured":"Oshun PO, Oduyebo OO, Ogunsola FT. The effects of antiviral therapy of genital herpes in HIV-infected individuals (Protocol). Cochrane Database of Systematic Reviews; 2007;(2):CD006492. doi:10.1002\/14651858.CD006492 [consultado 20\/8\/2009]. Disponible en: http:\/\/mrw.interscience.wiley.com\/cochrane\/clsysrev\/articles\/CD006492\/frame.html.","DOI":"10.1002\/14651858.CD006492"},{"key":"10.1016\/j.eimc.2009.11.002_bib39","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/339326","article-title":"Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment","volume":"34","author":"Leone","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.11.002_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/498521","article-title":"Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: A randomized, double-blind, placebo-controlled trial","volume":"42","author":"Aoki","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.11.002_bib41","unstructured":"Bouza E, Hell\u00edn T, Rodr\u00edguez Pichardo A, Ribera E. VIII-Enfermedades de transmisi\u00f3n sexual. En: Aguado JM, Almirante B, Fort\u00fan J, editores. Protocolos cl\u00ednicos de la SEIMC. 2005. [consultado 27\/7\/2009]. Disponible en: http:\/\/www.seimc.org\/documentos\/protocolos\/clinicos\/"},{"key":"10.1016\/j.eimc.2009.11.002_bib42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000018014","article-title":"Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis","volume":"197","author":"Pechere","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.eimc.2009.11.002_bib43","unstructured":"Varitect CP. Human varicella-zoster immunoglobulin for intravenous use. Summary of Product Characteristics. Biotest Pharma GmbH. Landsteinerstrasse 5, D-63303 Dreieich. October 2004."},{"key":"10.1016\/j.eimc.2009.11.002_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00430-006-0032-z","article-title":"Herpes simplex and varicella-zoster virus infections during pregnancy: Current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections","volume":"196","author":"Sauerbrei","year":"2007","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.eimc.2009.11.002_bib45","series-title":"Flebogamma\u00ae (inmunoglobulina humana polivalente). Ficha t\u00e9cnica del producto","year":"2009"},{"key":"10.1016\/j.eimc.2009.11.002_bib46","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1212\/01.WNL.0000123261.00004.29","article-title":"Risk factors for postherpetic neuralgia in patients with herpes zoster","volume":"62","author":"Jung","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.eimc.2009.11.002_bib47","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/01.WNL.0000140708.62856.72","article-title":"Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"63","author":"Dubinsky","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.eimc.2009.11.002_bib48","doi-asserted-by":"crossref","unstructured":"Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review. PLoS Med 2(7): e164. doi:10.1371\/journal.pmed.0020164","DOI":"10.1371\/journal.pmed.0020164"},{"key":"10.1016\/j.eimc.2009.11.002_bib49","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2009.11.002_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1468-3083.2004.01119.x","article-title":"Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study","volume":"19","author":"Wassilew","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.eimc.2009.11.002_bib51","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1742-1241.2006.01155.x","article-title":"The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster","volume":"61","author":"Kurokawa","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.eimc.2009.11.002_bib52","first-page":"75","article-title":"Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster","volume":"37","author":"Shen","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.eimc.2009.11.002_bib53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1386-6532(03)00164-1","article-title":"Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial","volume":"29","author":"Shafran","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.eimc.2009.11.002_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0166-3542(03)00065-2","article-title":"Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: Results of a randomized, double-blind, multicentered study","volume":"59","author":"Wassilew","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.eimc.2009.11.002_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1157\/13059061","article-title":"Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS","volume":"22","author":"Ramos","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/INF.0b013e3181598315","article-title":"Foscarnet salvage therapy for acyclovir-resistant varicella zoster: Report of a novel thymidine kinase mutation and review of the literature","volume":"27","author":"Hatchette","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2009.11.002_bib57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11908-009-0031-5","article-title":"Prophylaxis against pulmonary viral and fungal infections in solid organ transplant recipients","volume":"11","author":"Peleg","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.eimc.2009.11.002_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1586\/14787210.5.2.217","article-title":"Current non-AIDS antiviral chemotherapy","volume":"5","author":"Rottinghaus","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.eimc.2009.11.002_bib59","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/586903","article-title":"Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older","volume":"197","author":"Arora","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2009.11.002_bib60","series-title":"Nervinex\u00ae (brivudina). Informaci\u00f3n t\u00e9cnica del producto","year":"2007"},{"key":"10.1016\/j.eimc.2009.11.002_bib61","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bcp.2004.07.039","article-title":"Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster","volume":"68","author":"De Clercq","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.eimc.2009.11.002_bib62","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2165\/00003495-200464180-00011","article-title":"Brivudin (bromovinyl deoxyuridine)","volume":"64","author":"Keam","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.eimc.2009.11.002_bib63","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1517\/17425240802450340","article-title":"Acyclovir delivery systems","volume":"5","author":"Cortesi","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.eimc.2009.11.002_bib64","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/14728214.13.3.393","article-title":"Emerging antiviral drugs","volume":"13","author":"De Clercq","year":"2008","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.eimc.2009.11.002_bib65","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1157\/13078802","article-title":"Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus infection in transplanted patients","volume":"23","author":"Torre-Cisneros","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib66","first-page":"587","article-title":"Infection in heart transplantation","volume":"25","author":"Gurgui","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib67","series-title":"Manual de trasplante hematopoy\u00e9tico","author":"Carreras","year":"2004"},{"key":"10.1016\/j.eimc.2009.11.002_bib68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1157\/13114394","article-title":"Indirect effects of cytomegalovirus infection in solid organ transplant recipients","volume":"26","author":"P\u00e9rez-Sola","year":"2008","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.11.002_bib69","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","article-title":"Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients","volume":"9","author":"Asberg","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.eimc.2009.11.002_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/523590","article-title":"Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients","volume":"46","author":"Len","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.11.002_bib71","unstructured":"National Comprehensive Cancer network (NCCN). Clinical Practice Guidelines in Oncology. Prevention and treatment of cancer related infections V1; 2008 [consultado 20\/8\/2009]. Disponible en: http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#detection."},{"key":"10.1016\/j.eimc.2009.11.002_bib72","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2009.11.002_bib73","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/507337","article-title":"Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: A meta-analysis comparing prophylactic and preemptive therapies","volume":"43","author":"Small","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.11.002_bib74","doi-asserted-by":"crossref","unstructured":"Hodson EM, Craig JC, Strippoli GFM, Webster AC. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD003774. doi:10.1002\/14651858.CD003774.pub3.","DOI":"10.1002\/14651858.CD003774.pub3"},{"key":"10.1016\/j.eimc.2009.11.002_bib75","unstructured":"Cytovene IV (Ganciclovir). Full prescribing information. New Jersey: Roche; 2008."},{"key":"10.1016\/j.eimc.2009.11.002_bib76","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1182\/blood-2005-09-3786","article-title":"Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation","volume":"107","author":"Einsele","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.eimc.2009.11.002_bib77","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1345\/aph.1L065","article-title":"Maribavir: A novel antiviral agent with activity against cytomegalovirus","volume":"42","author":"Trofe","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.eimc.2009.11.002_bib78","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.transproceed.2008.03.084","article-title":"Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: A pooled analysis of clinical trials","volume":"40","author":"Demopoulos","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.eimc.2009.11.002_bib79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/14656560802678138","article-title":"Antiviral treatment of cytomegalovirus infection and resistant strains","volume":"10","author":"Schreiber","year":"2009","journal-title":"Expert Opin Pharmacother"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09005047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09005047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T19:34:04Z","timestamp":1558899244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X09005047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0213005X09005047"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2009.11.002","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}